IPAD-DB ID | D00422 |
Name | 2,3-bis(3'-hydroxybenzyl)butyrolactone |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 8 H 1 8 O 4 |
Molecular Weight | 298.3 |
IUPAC Name | 3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one |
InChI | InChI=1S/C18H18O4/c19-15-5-1-3-12(8-15)7-14-11-22-18(21)17(14)10-13-4-2-6-16(20)9-13/h1-6,8-9,14,17,19-20H,7,10-11H2 |
InChIKey | HVDGDHBAMCBBLR-UHFFFAOYSA-N |
Canonical SMILES | C1C(C(C(=O)O1)CC2=CC(=CC=C2)O)CC3=CC(=CC=C3)O |
PubChem CID | 123917 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 298.33 |
Hac(Computed by SwissADME) | 22 |
Volume(Computed by ADMETlab 2.0) | 310.921 |
Density(Computed by ADMETlab 2.0) | 0.959 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 18 |
Flexibility(Computed by ADMETlab 2.0) | 0.222 |
Stero Centers(Computed by ADMETlab 2.0) | 2 |
LogS(Computed by ADMETlab 2.0) | -3.201 |
LogD(Computed by ADMETlab 2.0) | 3.206 |
logP(Computed by ADMETlab 2.0) | 3.19 |
TPSA(Computed by SwissADME) | 66.76 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 4 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.76 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |